| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5691887 | Urology | 2016 | 24 Pages |
Abstract
Although the lymphocele rate with Arista AH was 5.7% compared with 10.2% without it, this was not a statistically significant difference potentially because the study was underpowered due to an unusually low baseline rate of lymphoceles. A larger study is warranted to determine whether using a hemostatic agent like Arista AH can prevent lymphoceles.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Daniel R. Gilbert, Jordan Angell, Ronney Abaza,